Similar Medicine Of Fibrolac Powder SF 90gm
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Fibrolac Powder SF 90gm
This combination is used to improve digestive health and provide relief from the problem of constipation
How Fibrolac Powder SF 90gm works
Present two active constituents Lactitol and Isaphgol effectively relieve constipation by facilitating stool elimination. Lactilol is a laxative that softens the stool by attracting water into the bowel. Isaphgol attract water in the intestine, due to which a gel-like substance form that facilitate bowel movements by adding bulk to the stool and allow it to pass easily.
How To Use Fibrolac Powder SF 90gm
- Follow the recommended dosage and consult doctor if any side effect
Special Precautions About Fibrolac Powder SF 90gm
- Notify your physician if: You have an allergy to any of the medication''s other ingredients or to this particular medication
Benefits Of Fibrolac Powder SF 90gm
- It is used for the treatment of constipation and improving digestive health It is also effective in weight management
Side Effects Of Fibrolac Powder SF 90gm
- Gas, Bloating, Itching, Rash
What If I Missed A Dose Of Fibrolac Powder SF 90gm
Health And Lifestyle
Drug Interaction
- Anticoagulant (Warfarin)
Drug Food Interaction
- N/A
Disease Explanation

A common digestive problem called constipation is characterized by irregular bowel motions or trouble passing feces. Frequently, it is accompanied by firm, dry stools that are challenging to pass.
Safety Advice for Fibrolac Powder SF 90gm
- High risk
- Moderate risk
- Safe
Generally considered safe; however, consult your healthcare provider if you have liver disease.
No known interactions with alcohol.
Consult your doctor before using.
No known effects on driving ability.
Generally considered safe; however, consult your healthcare provider if you have kidney disease.
Written By
Ashwani Singh
Master in Pharmacy
Content Updated on
Wednesday, 8 January, 2025